|
About the e-drug category
|
|
0
|
54
|
June 19, 2023
|
|
Patent status for essential medicines in LMICs
|
|
0
|
12
|
November 25, 2024
|
|
Risdiplam - an essential medicine for SMA
|
|
0
|
5
|
November 25, 2024
|
|
WHO: Urgent action needed as global diabetes cases increase four-fold over past decades
|
|
0
|
4
|
November 25, 2024
|
|
Low- And Middle-Income Countries Experienced Delays Accessing New Essential Medicines, 1982-2024
|
|
0
|
4
|
November 25, 2024
|
|
Exploring the feasibility of sharing information on medicine prices across countries OECD Health Working Papers No. 171
|
|
0
|
11
|
November 25, 2024
|
|
Access to diabetes treatment and care: new film launches Friday 29 November
|
|
0
|
11
|
November 23, 2024
|
|
Webinar: Framework Agreements in Humanitarian Settings Dec. 10, 2024 at 9 AM ET/14:00 UTC
|
|
0
|
4
|
November 23, 2024
|
|
Vacancies: CoE for Strengthening Health Products Safety Monitoring across Southern African Countries (UWC)
|
|
0
|
12
|
November 14, 2024
|
|
Webinar: Introducing the Monitoring Access to Insulin (MAIn) Tool and Dashboard, 12 November
|
|
0
|
33
|
November 8, 2024
|
|
The New Helsinki Declaration is out
|
|
0
|
33
|
October 19, 2024
|
|
Access to medicines among asylum seekers, refugees and undocumented migrants across the migratory cycle in Europe
|
|
0
|
10
|
October 17, 2024
|
|
Paper on A four-year assessment of the characteristics of Rwandan FDA drug recalls
|
|
0
|
9
|
October 16, 2024
|
|
Malaria vaccine rollout begins in Africa - need to strengthen regulatory & safety surveillance
|
|
0
|
23
|
October 13, 2024
|
|
QUAMED Learning Post on E-Drug
|
|
0
|
33
|
October 11, 2024
|
|
Understanding the evolution and governance of the WHO EML over the past 20 years
|
|
0
|
15
|
October 8, 2024
|
|
Measuring the value of the WHO Model list of essential medicines; and visions for the future
|
|
0
|
24
|
October 8, 2024
|
|
Antifreeze Detection in Cough Syrups: GPHF-Minilab Manual - Special Edition 2024
|
|
0
|
20
|
September 24, 2024
|
|
Retrospective study of medicine quality‑related complaints in Kenya’s PV database
|
|
0
|
14
|
September 24, 2024
|
|
Join Our Open House Webinar: Help Shape the Future of MQAS Standards
|
|
0
|
18
|
September 24, 2024
|
|
Vertex and U.K. reach deal to provide CRISPR-based medicine to thalassemia patients in England
|
|
0
|
10
|
August 8, 2024
|
|
Pharma industry urges Indian govt for stable drug pricing policy
|
|
0
|
10
|
August 6, 2024
|
|
World Local Production Forum 2023 - Report of 2nd meeting in Netherlands
|
|
1
|
24
|
August 8, 2024
|
|
SDG Indicator for access to medicines (3.b.3) at risk of being deleted
|
|
1
|
35
|
August 7, 2024
|
|
WHO policy brief: Antibacterial pipeline trends and recommendations to enhance research and development: policy brief
|
|
0
|
7
|
August 6, 2024
|
|
Prevalence of substandard, falsified, unlicensed and unregistered medicine and its associated factors in Africa: a systematic review - PubMed
|
|
0
|
13
|
August 5, 2024
|
|
Measuring access to essential medicines in the sustainable development goals
|
|
0
|
51
|
August 3, 2024
|
|
Prevalence of SF medicines and its associated factors in Africa: a systematic review
|
|
0
|
37
|
August 2, 2024
|
|
WHO/EURO: Novel Medicines Platform builds consensus
|
|
0
|
21
|
August 1, 2024
|
|
WHO/EURO: Containing cost and optimizing use of medical products
|
|
0
|
9
|
August 1, 2024
|